TY - JOUR
T1 - Management and outcomes of congestive heart failure
T2 - A prospective study of hospitalised patients
AU - Lowe, Julia M.
AU - Candlish, Paula M.
AU - Henry, David A.
AU - Wlodarcyk, John H.
AU - Heller, Richard F.
AU - Fletcher, Peter J.
PY - 1998/2/2
Y1 - 1998/2/2
N2 - Objectives: To characterise the morbidity, mortality and patterns of care for patients hospitalised with congestive heart failure (CHF). Design: Prospective cohort study with one-year follow-up. Patients: 409 patients aged 60 years and over admitted to hospital with congestive heart failure between 1 May and 30 November 1993. Setting: John Hunter Hospital (tertiary referral for cardiology) and Mater Hospital (non-tertiary referral for cardiology), Newcastle, New South Wales. Outcome measures: Length of hospital stay (LOS); unplanned readmissions; mortality at 28 days and one year; and relationship between outcomes and patient and disease characteristics determined by multivariate analysis. Results: Annual hospitalisation rate for CHF in the 60 years and over age group was 783/100,000, with CHF accounting for 10.9% of patients in this age group. Median LOS was eight days, and varied significantly between hospitals. ACE inhibitors were being taken by 66% of subjects at discharge. Rate of unplanned readmissions within 28 days was 20%. Mortality was 12.5% at 28 days and 33% at one year. For a first admission for CHF, 28-day mortality was lower than for readmissions (odds ratio, 0.25; 95% confidence interval, 0.1-0.62), and average LOS was 17% lower. Increasing age and renal impairment were significantly associated with higher one-year mortality. Greater comorbidity was associated significantly with longer LOS and non-significantly with higher 28-day and one-year mortality. Conclusions: CHF is a common reason for admission, often results in unplanned readmissions, and has a high mortality. Undertreatment with ACE inhibitors continues. The importance of avoiding recurrent admissions was clear. A program of intensive case management may reduce the burden attributable to CHF.
AB - Objectives: To characterise the morbidity, mortality and patterns of care for patients hospitalised with congestive heart failure (CHF). Design: Prospective cohort study with one-year follow-up. Patients: 409 patients aged 60 years and over admitted to hospital with congestive heart failure between 1 May and 30 November 1993. Setting: John Hunter Hospital (tertiary referral for cardiology) and Mater Hospital (non-tertiary referral for cardiology), Newcastle, New South Wales. Outcome measures: Length of hospital stay (LOS); unplanned readmissions; mortality at 28 days and one year; and relationship between outcomes and patient and disease characteristics determined by multivariate analysis. Results: Annual hospitalisation rate for CHF in the 60 years and over age group was 783/100,000, with CHF accounting for 10.9% of patients in this age group. Median LOS was eight days, and varied significantly between hospitals. ACE inhibitors were being taken by 66% of subjects at discharge. Rate of unplanned readmissions within 28 days was 20%. Mortality was 12.5% at 28 days and 33% at one year. For a first admission for CHF, 28-day mortality was lower than for readmissions (odds ratio, 0.25; 95% confidence interval, 0.1-0.62), and average LOS was 17% lower. Increasing age and renal impairment were significantly associated with higher one-year mortality. Greater comorbidity was associated significantly with longer LOS and non-significantly with higher 28-day and one-year mortality. Conclusions: CHF is a common reason for admission, often results in unplanned readmissions, and has a high mortality. Undertreatment with ACE inhibitors continues. The importance of avoiding recurrent admissions was clear. A program of intensive case management may reduce the burden attributable to CHF.
UR - http://www.scopus.com/inward/record.url?scp=0032472896&partnerID=8YFLogxK
M3 - Article
C2 - 9484328
AN - SCOPUS:0032472896
SN - 0025-729X
VL - 168
SP - 115
EP - 118
JO - Medical Journal of Australia
JF - Medical Journal of Australia
IS - 3
ER -